Quinlukast
Alternative Names: VUFB 19363Latest Information Update: 14 Apr 2010
At a glance
- Originator VUFB
- Developer VUFB; Zentiva
- Class Antiasthmatics; Benzoic acids; Small molecules
- Mechanism of Action Leukotriene receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Inflammation
Most Recent Events
- 31 Jan 2004 Preclinical trials in Asthma in Czech Republic (unspecified route)
- 31 Jan 2004 Preclinical trials in Inflammation in Czech Republic (unspecified route)
- 18 Dec 2003 No development reported - Preclinical for Asthma in Czech Republic (unspecified route)